Citations |
1. Biomaterials 34, 9171 (2013). http://dx.doi.org/10.1016/j.biomaterials.2013.08.039
2. J Control Release (2013) http://dx.doi.org/10.1016/j.jconrel.2013.10.002
3. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2013.09.094
4. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2013.09.089
5. International Journal of Nanomedicine 8, 2473-2485 (2013).
6. Bioconjugate Chemistry (2013) doi: 10.1021/bc400055h
7. International Journal of Pharmaceutics (2013), http://dx.doi.org/10.1016/j.ijpharm.2013.05.015
8. Pharm Res (2013) doi: 10.1007/s11095-013-1055-y
9. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2013.03.097
10. International Journal of Nanomedicine 8, 1573-1593 (2013)
11. International Journal of Nanomedicine 8, 1463-1476 (2013)
12. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2013.03.036
13. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2013.02.013
14. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2012.12.049
15. Biomaterials (2012), http://dx.doi.org/10.1016/j.biomaterials.2012.12.012
16. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2012.11.016
17. International Journal of Nanomedicine 7, 163-175 (2012)
18. J. Control. Release (2012) doi:10.1016/j.jconrel.2011.12.017
19. Pharm Res (2011) doi: 10.1007/s11095-011-0641-0
20. Biomaterials (2011) doi:10.1016/j.biomaterials.2011.10.035
21. International Journal of Pharmaceutics (2011) doi:10.1016/j.ijpharm.2011.09.008
22. Molecular Pharmaceutics (2011) doi: 10.1021/mp200100f
23. International Journal of Pharmaceutics (2011) doi:10.1016/j.ijpharm.2011.08.052
24. International Journal of Pharmaceutics (2011) doi:10.1016/j.ijpharm.2011.07.021
25. Molecular Pharmaceutics (2010) doi: 10.1021/mp100277h
26. Journal of Controlled Release (2013), http://dx.doi.org/10.1016/j.jconrel.2013.10.026
27. Biomaterials (2013), http://dx.doi.org/10.1016/j.biomaterials.2013.09.062
28. PLoS ONE (2013), doi:10.1371/journal.pone.0085003
29. Int J Pharmaceut (2013), http://dx.doi.org/10.1016/j.ijpharm.2013.12.016
30. Journal of Drug Targeting (2014), http://informahealthcare.com/doi/abs/10.3109/1061186X.2013.851683
31. ACS Nano (2014), doi: 10.1021/nn405155b
32. Molecular Pharmaceutics (2014), doi: 10.1021/mp400751g
33. Int J Pharmaceut (2014), http://dx.doi.org/10.1016/j.ijpharm.2014.03.012
34. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.03.012
35. Int J Pharmaceut (2014), http://dx.doi.org/10.1016/j.ijpharm.2014.04.008
36. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.03.036
37. Drug Delivery (2014), doi:10.3109/10717544.2014.903580
38. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.04.031
39. Pharm Res. (2014), doi: 10.1007/s11095-014-1400-9
40. Small (2014), doi: 10.1002/smll.201302786
41. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.04.117
42. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.06.022
43. Mol. Pharmaceutics (2014), dx.doi.org/10.1021/mp500113p
44. Vaccine (2014), http://dx.doi.org/10.1016/j.vaccine.2014.07.081
45. Journal of controlled release (2014), http://dx.doi.org/10.1016/j.jconrel.2014.09.029
46. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.09.008
47. International Journal of Nanomedicine 9, 5261-5271(2014).
48. Journal of pharmaceutical sciences (2014), doi: 10.1002/jps.24291
49. Biomaterials (2014), http://dx.doi.org/10.1016/j.biomaterials.2014.11.044
50. Int J Pharmaceut (2014), http://dx.doi.org/10.1016/j.ijpharm.2014.12.039
51. Acta Biomater (2015), http://dx.doi.org/10.1016/j.actbio.2015.01.010
52. Polym. Chem. (2015), doi: 10.1039/C4PY01422G
53. Biointerfaces (2015), http://dx.doi.org/10.1016/j.colsurfb.2015.02.041
54. ONCOLOGY LETTERS (2015), doi: 10.3892/ol.2015.3242
55. Acta Biomaterialia (2015), http://dx.doi.org/10.1016/j.actbio.2015.05.021
56. Drug Delivery (2015), http://informahealthcare.com/doi/abs/10.3109/10717544.2015.1040527
57. Journal of Drug Targeting (2015), doi:10.3109/1061186X.2015.1058800
58. Journal of drug targeting (2015), doi:10.3109/1061186X.2015.1064435
59. Nanomedicine (2015), doi:10.2217/nnm.15.106
60. Molecular Pharmaceutics (2015), doi: 10.1021/acs.molpharmaceut.5b00222
61. Bio-Medical Materials and Engineering 26 (2015), doi: 10.3233/BME-151384
62. ACS Appl. Mater. Interfaces (2015), doi: 10.1021/acsami.5b06043
63. International Journal of Pharmaceutics (2015), doi:10.1016/j.ijpharm.2015.12.013
64. RSC Advances (2015), doi: 10.1039/c5ra22233h
65. Applied Materials Interfaces (2015), doi: 10.1021/acsami.5b09934 |
Description |
DiIC 18(7); 1, 1'-dioctadecyl-3, 3, 3', 3'-tetramethylindotricarbocyanine iodide DiR is a lipophilic, near-infrared fluorescent cyanine dye. The dye is useful for labeling cytoplasmic membrane. The two long 18-carbon chains insert into the cell membrane, resulting in specific and stable cell staining with no or minimal dye transfer between cells. A stock solution of the dye can be made in ethanol. Cell staining can be effected using the dye at 1-10 uM concentration and 10-20 min incubation time. Please also see our other cytoplasmic membrane dyes. DiR, DiD, DiI and Neuro-DiO can be used in combination for multicolor imaging. - Ex/Em (MeOH) = 748/780 nm
- μ = 270, 000
- Dark blue-green oily solid soluble in ethanol, DMF or DMSO
- Store at -20°C
- C63H101IN2
- MW: 1013.4
|